Related Experiment Video
Updated: Jan 11, 2026

04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
26.2K
Development of a Novel Murine Model of In-Stent Neoatherosclerosis
Jiandi Liu1,2,3, Demeke Geremew1,2,4, Lauren Y Sandeman1
1Vascular Research Centre, Lifelong Health Theme South Australian Health and Medical Research Institute (SAHMRI) Adelaide South Australia Australia.
Journal of the American Heart Association
|November 12, 2025
Summary
Researchers developed a new mouse model for in-stent neoatherosclerosis, a complication of coronary stenting. This model mimics human disease, enabling studies on mechanisms and therapies for this condition.
Area of Science:
- Cardiovascular Research
- Translational Medicine
- Animal Models
Background:
- In-stent neoatherosclerosis is a post-stenting complication developing within 1-5 years.
- Current lack of preclinical small animal models hinders research into neoatherosclerosis biology and therapies.
Purpose of the Study:
- Establish and validate a novel murine model for in-stent neoatherosclerosis.
- Provide a platform for studying disease mechanisms and evaluating targeted treatments.
Main Methods:
- Stainless-steel stents implanted in donor aortas of apolipoprotein E-deficient (Apoe-/-) mice, then grafted into recipients.
- Mice fed high-cholesterol diet post-surgery; stented vessels assessed using bimodal intravascular imaging (OCT and fluorescence) and histology.
- Flow cytometry used to analyze cellular content of stented aortas.
Main Results:
- Bimodal imaging visualized in-stent neoatherosclerosis, including plaque burden and instability.
- High-cholesterol diet induced neointimas with lipid cores and macrophages, mimicking human neoatherosclerosis.
- Distinct neointimas (smooth muscle cell-rich) observed in mice on chow diet, resembling neointimal hyperplasia.
Conclusions:
- Successfully developed and validated the first murine model of human in-stent neoatherosclerosis.
- This model is crucial for investigating neoatherosclerosis pathogenesis.
- Enables preclinical testing of novel therapeutic strategies for in-stent neoatherosclerosis.

